S. Pocock

First name

S.

Last name

Pocock

Qizilbash, N., Kataria, H., Jarman, H., Bloom, B., Bradney, M., Oh, M., et al. (2023). Real world safety of methoxyflurane analgesia in the emergency setting: a comparative hybrid prospective-retrospective post-authorisation safety study. Bmc Emerg Med, 23, 100. http://doi.org/10.1186/s12873-023-00862-2

View

Kim, J., Evans, S., Smeeth, L., & Pocock, S. (2006). Hormone replacement therapy and acute myocardial infarction: a large observational study exploring the influence of age. Int J Epidemiol. http://doi.org/10.1093/ije/dyi285

View

Douglas, I. J., Evans, S. J., Pocock, S., & Smeeth, L. (2009). The risk of fractures associated with thiazolidinediones: a self-controlled case-series study. PLoS Med. http://doi.org/10.1371/journal.pmed.1000154

View

Wilding, J. P. H., Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., et al. (2017). Changes in HbA1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice. Diabetologia.

View

Wilding, J., Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., et al. (2018). Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink. BMC Med. http://doi.org/10.1186/s12916-018-1085-8

View

Gregson, J., Qizilbash, N., Iwagami, M., Douglas, I., Johnson, M., Pearce, N., & Pocock, S. (2019). Blood pressure and risk of dementia and its subtypes: a historical cohort study with long-term follow-up in 2.6~million people. Eur J Neurol. http://doi.org/10.1111/ene.14030

View

Iwagami, M., Qizilbash, N., Gregson, J., Douglas, I., Johnson, M., Pearce, N., et al. (2021). Blood cholesterol and risk of dementia in more than 1.8 million people over two decades: a retrospective cohort study. Lancet Healthy Longev. http://doi.org/10.1016/S2666-7568(21)00150-1

View